Connect with us

Hi, what are you looking for?

Economy

Manila starts vaccination of health workers

By Vann Marlo M. Villegas, Reporter

THE PHILIPPINES started immunizing its most vulnerable people against the coronavirus on Monday after receiving 600,000 doses of CoronaVac donated by China.

The head of the state-owned Philippine General Hospital (PGH) in Manila was the first to get the shot made by Chinese drug maker Sinovac Biotech Ltd.

Aside from PGH Director Gerardo D. Legaspi, also vaccinated at the hospital were Food and Drug Administration’s (FDA) Rolando Enrique Domingo and infectious disease expert Edsel T. Salvana.

Vaccine czar Carlito G. Galvez, Jr. said the economy would not recover and life would not return to normal if people don’t get vaccinated. Vaccination is a “moral obligation,” he told a televised news briefing before the start of the rollout.

“Let’s not wait for the so-called best vaccine,” he said in Filipino. “There is no such best vaccine because the best vaccine is the one that is effective, efficient and arrives early.”

The government would try to vaccinate all local health workers this month, Mr. Galvez said.

A hundred PGH workers were inoculated with the CoronaVac, Mr. Legaspi told an online news briefing.

Hospital spokesman Jose Jonas D. del Rosario said at the weekend only 12% of the 2,500 hospital staff who answered a poll wanted to take the CoronaVac shots.

Mr. del Rosario on Sunday said those who declined to get vaccinated with CoronaVac would still be prioritized once other vaccine brands arrive.

The vaccinations were also held at five other hospitals in Metro Manila: Lung Center of the Philippines, Dr. Jose N. Rodriguez Memorial Medical Center Sanitarium, Veterans Memorial Medical Center, Philippine National Police General Hospital and Victoriano Luna Medical Center.

Testing czar Vivencio B. Dizon was vaccinated at the Sanitarium.

CoronaVac is only 50.2% effective among health workers, based on trials in Turkey. It was 65.3% to 91.2% effective among patients aged 18 to 59 years, based on trials in Indonesia.

An inter-agency task force allowed the Chinese vaccine to be given to health frontliners. Presidential spokesman Harry L. Roque, Jr. earlier said CoronaVac is safe and would benefit health workers.

Sinovac’s CoronaVac is one of the frontrunners in the vaccine race, along with shots developed by British drug maker AstraZeneca Plc, Russia’s Gameleya National Center of Epidemiology and Microbiology, and America’s Pfizer, Inc., Moderna, Inc. and Johnson & Johnson.

It is the third coronavirus vaccine approved by the country’s Food and Drug Administration for emergency use after the ones from Pfizer and AstraZeneca.

The local FDA last week approved Sinovac’s vaccine for emergency use, the third drug after vaccines from Pfizer, Inc. and AstraZeneca Plc.

The arrival of 525,600 doses of vaccine made by AstraZeneca Plc, originally set for March 1, would be delayed by a week due to global supply problems, Health Secretary Francisco T. Duque III said on Sunday.

TALLY
The Department of Health (DoH) reported 2,037 cases on Monday, bringing the total to 578,381.

The death toll rose by four to 12,322, while recoveries increased by 86 to 534,351, it said in a bulletin.

There were 31,708 active cases, 89.3% of which were mild, 5% did not show symptoms, 2.5% were critical, 2.3% were severe and 0.89% were moderate.

The DoH said eight duplicates had been removed from the tally. One laboratory failed to submit data on Feb. 28.

About 8.3 million Filipinos have been tested for the coronavirus as of Feb. 27, according to DoH’s tracker website.

The coronavirus has sickened around 114.7 million and killed more than 2.5 million people worldwide, according to the Worldometers website, citing various sources including data from the World Health Organization (WHO).

About 90.3 million people have recovered, it said.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest

Investing

We all know that AI is crucial and the future of the internet for smart marketing within businesses. Appu Shaji predicted this early on...

Economy

As celebrations continue this September, dubbed as 917 month, Globe hopes to rally its customers to help in the fight against COVID-19 by encouraging...

Investing

Ford has announced a major investment in electric vehicle (EV) production in the US, promising to build its biggest ever factory in Tennessee, and...

Investing

A clean energy investment fund run by former US vice-president Al Gore has bought a 13% stake in British energy company Octopus in a...

Economy

National Artist for Literature Bienvenido “Bien” Lumbera passed away on the morning on Sept. 28, 9 a.m., due to “complications of stroke,” said his family. He was 89...

Economy

A Chinese flag is seen on the top of a car near a coal-fired power plant in Harbin, Heilongjiang province, China Nov. 27, 2019....

You May Also Like

Investing

Having a good Instagram marketing agency to back up your Instagram account is an absolute must going into the new year. With competition stronger...

Economy

Ivermectin, an existing drug against parasites including head lice, has had a checkered history when it comes to treating COVID-19. The bulk of studies...

Investing

As a traditionally rigid insurance industry becomes bogged down by antiquated processes and operations, a handful of industry leaders are seeking to shake things...

Economy

US President Joseph R. Biden, Jr., will rely on ally countries to supply the bulk of the metals needed to build electric vehicles and focus on...

Disclaimer: SmartRetirementReport.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2021 SmartRetirementReport. All Rights Reserved.

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.



Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!